€21.84
0.74% yesterday
Amsterdam, Apr 17, 05:35 pm CET
ISIN
BE0003818359
Symbol
GLPG
Sector
Industry

Galapagos Stock price

€21.84
-2.04 8.54% 1M
-6.04 21.66% 6M
-4.68 17.65% YTD
-5.54 20.23% 1Y
-38.80 63.98% 3Y
-171.71 88.72% 5Y
-9.26 29.77% 10Y
Amsterdam, Closing price Thu, Apr 17 2025
+0.16 0.74%
ISIN
BE0003818359
Symbol
GLPG
Sector
Industry

Key metrics

Market capitalization €1.44b
Enterprise Value €-1.71b
P/E (TTM) P/E ratio 19.43
EV/FCF (TTM) EV/FCF 5.56
EV/Sales (TTM) EV/Sales -6.20
P/S ratio (TTM) P/S ratio 5.22
P/B ratio (TTM) P/B ratio 0.50
Revenue (TTM) Revenue €275.65m
EBIT (operating result TTM) EBIT €-229.11m
Free Cash Flow (TTM) Free Cash Flow €-307.25m
Cash position €3.16b
EPS (TTM) EPS €1.12
P/E forward negative
P/S forward 5.99
EV/Sales forward negative
Show more

Is Galapagos a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,780 stocks worldwide.

Galapagos Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Galapagos forecast:

1x Buy
9%
8x Hold
73%
2x Sell
18%

Analyst Opinions

11 Analysts have issued a Galapagos forecast:

Buy
9%
Hold
73%
Sell
18%

Financial data from Galapagos

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
276 276
-
100%
- Direct Costs 35 35
-
13%
241 241
-
87%
- Selling and Administrative Expenses 134 134
-
49%
- Research and Development Expense 335 335
-
122%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -229 -229
-
-83%
Net Profit 74 74
-
27%

In millions EUR.

Don't miss a Thing! We will send you all news about Galapagos directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Galapagos Stock News

Neutral
GlobeNewsWire
3 days ago
Mechelen, Belgium; April 15, 2025, 07:30 CET; regulated information – inside information – Galapagos NV (Euronext & NASDAQ: GLPG), a global biotechnology company dedicated to transforming patient outcomes through life-changing science and innovation, today announced the departure of its CFO and COO, Thad Huston, effective as of August 1, 2025. Mr. Huston has decided to leave the company and ret...
Neutral
GlobeNewsWire
22 days ago
Mechelen, Belgium; March 27, 2025, 21:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) today publishes its annual report for the financial year 2024 and announces its Annual Shareholders' Meeting (AGM) to be held on Tuesday, April 29, 2025 at 14:00 CET at the registered office of the Company.
Neutral
GlobeNewsWire
about 2 months ago
Mechelen, Belgium; February 24, 2025, 22:01 CET – Galapagos NV (Euronext & NASDAQ: GLPG), a global biotechnology company dedicated to transforming patient outcomes through life-changing science and innovation, today announced that its management will present at the following investor conferences in March: TD Cowen 45 th Annual Healthcare Conference  Date: Tuesday, March 4, 2025Location: Boston,...
More Galapagos News

Company Profile

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research & Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Head office Belgium
CEO Paulus Stoffels
Employees 704
Founded 1999
Website www.glpg.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today